Source: Marketing Authorisation Holder Revision Year: 2018 Publisher: Dafra Pharma GmbH, Mühlenberg 7, 4052 Basel, Switzerland Manufacturer: Bilim Pharmaceuticals, GOSB 41480 Gebze, Kocaeli, Turkey
Add-on therapy for painful muscle contractures in acute spinal pathology in adults and adolescents 16 years of age and older.
The recommended and maximum dose is 8 mg every 12 hours (i.e. 16 mg daily). The length of treatment is limited to 7 consecutive days.
Doses higher than the recommended doses or long-term use should be avoided (see Section 4.4).
Muscurel should not be used in children or adolescents less than 16 years of age because of safety concerns (see Section 5.3).
Oral use.
The capsules must be swallowed with a glass of water.
Digestive signs of the diarrhoea or vomiting type are possible.
In case of an overdose, monitoring by a physician and symptomatic treatment are recommended.
3 years.
Do not store above 30°C.
Cardboard box with one transparent PVC/Al blister package of 10 capsules.
No special requirements.
Any unused product or waste material should be disposed of in accordance with the regulations in force.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.